Interleukin-10: An Important Immunoregulatory Cytokine With Major Impact on Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
185-192
Author(s):
Khusru Asadullah, Robert Sabat, Markus Friedrich, Hans Dieter Volk and Wolfram Sterry
Immune Deviation Strategies in the Therapy of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
193-198
Author(s):
Kamran Ghoreschi and Martin Rocken
Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
205-211
Author(s):
Stephane Kuenzli and Jean-Hilaire Saurat
Histone Deacetylase Inhibitors in Psoriasis Therapy
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
213-219
Author(s):
Fiona McLaughlin and Nicholas B. La Thangue
Recent Advances in the Imaging of Programmed Cell Death
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1457-1467
Author(s):
Francis G. Blankenberg
Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
267-283
Author(s):
X. Chen, S. Wang, N. Wu and C. S. Yang
Chinese Herbs as Immunomodulators and Potential Disease-Modifying Antirheumatic Drugs in Autoimmune Disorders
Journal:
Current Drug Metabolism
Volume:
5
Page:
181-192
Author(s):
Ling-Jun Ho and Jenn-Haung Lai
The Histopathology of Spondyloarthropathy
Journal:
Current Molecular Medicine
Volume:
4
Page:
1-12
Author(s):
Dominique Baeten and Filip De Keyser
Animal Models of HLA-B27-Associated Diseases
Journal:
Current Molecular Medicine
Volume:
4
Page:
31-40
Author(s):
Maxime Breban, Cecile Hacquard-Bouder and Geraldine Falgarone
Recognition of Classical and Heavy Chain Forms of HLA-B27 by Leukocyte Receptors
Journal:
Current Molecular Medicine
Volume:
4
Page:
59-65
Author(s):
Rachel L. Allen and John Trowsdale